424 10.1007/424.1432-2013 Pflügers Archiv - European Journal of Physiology Pflugers Arch - Eur J Physiol 0031-6768 1432-2013 Springer Berlin Heidelberg Berlin/Heidelberg s00424-020-02454-6 2454 10.1007/s00424-020-02454-6 Commentary Serotonin receptor HTR4 as a counter actor of lipid-induced increases of serum glucagon-like peptide-1 levels Breit Andreas 1 a Gudermann Thomas 1 1 grid.5252.0 0000 0004 1936 973X Walther Straub Institute of Pharmacology and Toxicology, Medical Faculty LMU Munich Goethestrasse 33 80336 Munich Germany a andreas.breit@lrz.uni-muenchen.de 22 8 2020 10 2020 472 10 1433 1434 14 8 2020 7 8 2020 7 8 2020 14 8 2020 22 8 2020 © The Author(s) 2020 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Ludwig-Maximilians-Universität München (1024) publisher-imprint-name Springer volume-issue-count 12 issue-article-count 12 issue-toc-levels 0 issue-pricelist-year 2020 issue-copyright-holder Springer-Verlag GmbH Germany, part of Springer Nature issue-copyright-year 2020 article-contains-esm No article-numbering-style Unnumbered article-registration-date-year 2020 article-registration-date-month 8 article-registration-date-day 14 article-toc-levels 0 toc-levels 0 volume-type Regular journal-product ArchiveJournal numbering-style Unnumbered article-grants-type OpenChoice metadata-grant OpenAccess abstract-grant OpenAccess bodypdf-grant OpenAccess bodyhtml-grant OpenAccess bibliography-grant OpenAccess esm-grant OpenAccess online-first false pdf-file-reference BodyRef/PDF/424_2020_Article_2454.pdf pdf-type Typeset target-type OnlinePDF issue-online-date-year 2020 issue-online-date-month 9 issue-online-date-day 7 issue-print-date-year 2020 issue-print-date-month 9 issue-print-date-day 7 issue-type Regular article-type EditorialNotes journal-subject-primary Biomedicine journal-subject-secondary Human Physiology journal-subject-secondary Molecular Medicine journal-subject-secondary Neurosciences journal-subject-secondary Cell Biology journal-subject-secondary Receptors journal-subject-collection Biomedical and Life Sciences open-access true body absent This article is a commentary to the original article 10.1007/s00424-020-02453-7
424 10.1007/424.1432-2013 Pflügers Archiv - European Journal of Physiology Pflugers Arch - Eur J Physiol 0031-6768 1432-2013 Springer Berlin Heidelberg Berlin/Heidelberg s00424-020-02454-6 2454 10.1007/s00424-020-02454-6 Commentary Serotonin receptor HTR4 as a counter actor of lipid-induced increases of serum glucagon-like peptide-1 levels Breit Andreas 1 a Gudermann Thomas 1 1 grid.5252.0 0000 0004 1936 973X Walther Straub Institute of Pharmacology and Toxicology, Medical Faculty LMU Munich Goethestrasse 33 80336 Munich Germany a andreas.breit@lrz.uni-muenchen.de 22 8 2020 10 2020 472 10 1433 1434 14 8 2020 7 8 2020 7 8 2020 14 8 2020 22 8 2020 © The Author(s) 2020 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Ludwig-Maximilians-Universität München (1024) publisher-imprint-name Springer volume-issue-count 12 issue-article-count 12 issue-toc-levels 0 issue-pricelist-year 2020 issue-copyright-holder Springer-Verlag GmbH Germany, part of Springer Nature issue-copyright-year 2020 article-contains-esm No article-numbering-style Unnumbered article-registration-date-year 2020 article-registration-date-month 8 article-registration-date-day 14 article-toc-levels 0 toc-levels 0 volume-type Regular journal-product ArchiveJournal numbering-style Unnumbered article-grants-type OpenChoice metadata-grant OpenAccess abstract-grant OpenAccess bodypdf-grant OpenAccess bodyhtml-grant OpenAccess bibliography-grant OpenAccess esm-grant OpenAccess online-first false pdf-file-reference BodyRef/PDF/424_2020_Article_2454.pdf pdf-type Typeset target-type OnlinePDF issue-online-date-year 2020 issue-online-date-month 9 issue-online-date-day 7 issue-print-date-year 2020 issue-print-date-month 9 issue-print-date-day 7 issue-type Regular article-type EditorialNotes journal-subject-primary Biomedicine journal-subject-secondary Human Physiology journal-subject-secondary Molecular Medicine journal-subject-secondary Neurosciences journal-subject-secondary Cell Biology journal-subject-secondary Receptors journal-subject-collection Biomedical and Life Sciences open-access true body absent This article is a commentary to the original article 10.1007/s00424-020-02453-7 ftp_PUB_20-09-08_05-04-59.zip 424-2020-Article-2454.pdf PDF 1.4